Search by Drug Name or NDC
NDC 00990-7941-09 Dextrose and Sodium Chloride 5; .9 g/100mL; g/100mL Details
Dextrose and Sodium Chloride 5; .9 g/100mL; g/100mL
Dextrose and Sodium Chloride is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by ICU Medical Inc.. The primary component is DEXTROSE MONOHYDRATE; SODIUM CHLORIDE.
Product Information
| NDC | 00990-7941 |
|---|---|
| Product ID | 0990-7941_8aad724e-964b-4eac-a915-5f5013d983f5 |
| Associated GPIs | 79993002202035 |
| GCN Sequence Number | 002001 |
| GCN Sequence Number Description | dextrose 5 % and 0.9 % NaCl IV SOLN 5 %-0.9 % INTRAVEN |
| HIC3 | C5K |
| HIC3 Description | IV SOLUTIONS: DEXTROSE-SALINE |
| GCN | 06931 |
| HICL Sequence Number | 000934 |
| HICL Sequence Number Description | DEXTROSE 5 % AND 0.9 % SODIUM CHLORIDE |
| Brand/Generic | Generic |
| Proprietary Name | Dextrose and Sodium Chloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | DEXTROSE MONOHYDRATE and SODIUM CHLORIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 5; .9 |
| Active Ingredient Units | g/100mL; g/100mL |
| Substance Name | DEXTROSE MONOHYDRATE; SODIUM CHLORIDE |
| Labeler Name | ICU Medical Inc. |
| Pharmaceutical Class | Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA017585 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00990-7941-09 (00990794109)
| NDC Package Code | 0990-7941-09 |
|---|---|
| Billing NDC | 00990794109 |
| Package | 12 POUCH in 1 CASE (0990-7941-09) / 1 BAG in 1 POUCH / 1000 mL in 1 BAG |
| Marketing Start Date | 2019-11-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |